Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05669027 · ClinicalTrials.gov registry record · NA
Mobile Neurofeedback for Low Back Pain
A NA study of Chronic Low Back Pain, sponsored by Duke University.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT05669027: Recruiting NA study of Chronic Low Back Pain, sponsored by Duke University.
NCT05669027 is a NA study of Chronic Low Back Pain that is actively recruiting participants, run by Duke University. The registered enrollment target is 150 participants, below the 590-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05669027, a NA study of Chronic Low Back Pain, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to learn more about improving the quality of treatments for people who have chronic low back pain. Participants will complete interviews with Duke researchers at four different time points: the beginning of the study, at 3 months, at 6 months, and at 9 months. Participants will be asked to use a mobile app and a headset that are designed to train the brain to be more relaxed. Participants will use the mobile app for 10 minutes at a time, four times a week for three months. The study team will also check in with participants about app use six times throughout the study, via phone or video conference.
Primary Outcome
Low back pain intensity on a 0-10 point rating scale, where higher scores indicate greater pain intensity.
Conditions Studied
Interventions
- DEVICE Neurofeedback
- DEVICE Sham (Placebo Control)
Study Locations (1)
North Carolina
- Duke University Medical Center, Department of Psychiatry - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2023-10-02 |
| Est. Completion | 2027-05-01 |
| Phase | NA |
What NCT05669027 shows while recruiting
NCT05669027 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 590-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Chronic Low Back Pain appearing as the primary indexed condition, and to 2 interventions - of which Neurofeedback is the first listed.
NCT05669027 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05669027 about?
NCT05669027 is a clinical study titled "Mobile Neurofeedback for Low Back Pain". The purpose of this study is to learn more about improving the quality of treatments for people who have chronic low back pain. Participants will complete interviews with Duke researchers at four different time points: the beginning of the study, at 3 months, at 6 months, and at 9 months. Participan...
What is the current status of trial NCT05669027?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2023-10-02. Estimated completion is 2027-05-01.
What conditions does trial NCT05669027 study?
This clinical trial studies the following conditions: Chronic Low Back Pain.
What interventions are being tested in trial NCT05669027?
The interventions under investigation include: Neurofeedback (DEVICE), Sham (Placebo Control) (DEVICE).
Who is sponsoring clinical trial NCT05669027?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05669027 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Low Back Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05669027's enrollment target sits among peer trials
150 24th of 71 higher than 48 of 71 other Chronic Low Back Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Low Back Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Phenotyping Response to Spinal Cord Stimulation in Chronic Low Back Pain
RECRUITING · NA
-
Active Music-Based Intervention in Patients With Chronic Low Back Pain
RECRUITING · NA
-
Sequential and Comparative Evaluation of Pain Treatment Effectiveness Response
RECRUITING · NA
-
Meditation for Older Adults With Chronic Low Back Pain
RECRUITING · NA
-
MBM andtaVNS for Low Back Pain and Depressive Symptoms
RECRUITING · NA
-
Telerehabilitation for Patients With Chronic Low Back Pain (TeleBACK Clinical Trial)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI